Homepage
Author:
Context Therapeutics Inc.
Posted Date:
January 22, 2026
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Context Therapeutics Inc.
January 22, 2026